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Endothelial cells respond to inflammatory stimuli with complex genetic alterations that determine the immune response and the outcome of the
inflammatory process. An additional layer of complexity is added by the different phenotypes and functional heterogeneity of endothelial cells in the
various tissues. To understand these complex gene response patterns and the regulatory pathways involved, many investigators increasingly use DNA
microarray analysis. There are, however, many potential pitfalls in the use of microarrays that can result in false data and erroneous conclusions. This
review surveys the principles of DNA microarray technology and its applications in endothelial cell research. We also attempt to outline some of the
caveats and standard criteria that have to be considered in order to realize the full potential of microarrays in inflammation research.
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Inflammatory processes are critically determined by the
vascular endothelium and its response to extracellular injury.
Distinct stimuli trigger different gene expression programs
resulting in the transcription of a characteristic battery of pro-
and anti-inflammatory proteins [1–3]. These molecules guide
attraction and interaction with leukocytes or platelets, affect
vascular permeability and coagulation, and finally control the
course and outcome of inflammatory reactions [4,5]. Conse-
quently, in vivo, a great variety of systemic inflammatory
response patterns can be observed, in which the endothelium is
involved and fulfills different functional tasks.
The final inflammatory process is a product of different
cellular systems and multiple molecular parameters. Addition-
ally, the inflammatory program is influenced by the diversity of
the vascular bed, which is crucially determined by the type of
endothelial cell (EC) lining the inner vessel surface. Most
researchers approach this complex situation by using primary
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information about endothelial stress responses.
The complex genetic processes underlying the endothelial
responses under certain conditions are currently only partly
understood. Apparently, different signaling pathways launch
distinct genetic programs in ECs depending on the inflamma-
tory stimulus. One way to determine the behavior of ECs in
response to different stimuli or pathogenic conditions is
through repeated measurements of RNA transcripts. Micro-
array technology allows now for the identification of RNA
transcripts on a genome-wide scale. Since EC lines are a well-
characterized and almost homogenous cell population, they
represent a suitable experimental setting for microarray
analyses. The definition of specific genetic inflammatory
response patterns in different vascular cell types and certain
disease states as well as the characterization of the signaling
pathways involved are prerequisites for the development of
new therapeutic strategies in inflammatory diseases.
2. Principles of microarray technology
The human genome project with the identification of more
than 3.5 million genetic sequences deposited in internationalta 1746 (2005) 73 – 84
http://www
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microarray technology. High-throughput microarrays are a
powerful tool to establish gene expression profiles from different
cells, tissues, developmental stages, disease states or samples
subjected to appropriate treatments. A microarray experiment
can provide data of the expression data of tens of thousands of
genes, more information than can be analyzed by a single study.
The most common tools for measuring gene expression are
DNA microarrays. There are two variants in terms of the array
DNA sequence that either include cDNAs immobilized to a solid
support such as glass or nylon membranes, or oligonucleotides
(20–80-mers) that are spotted on glass slides. The arrays are
hybridized with cDNA or cRNA probesmade from two samples,
which are labeled with distinct fluorescent dyes such as, forFig. 1. Expression analysis by microarray hybridization. The scheme sketches the dif
cDNA microarrays (A) and oligonucleotide-based microarrays (B).instance, Cy5 (red) and Cy3 (green) (Fig. 1A). Short oligonu-
cleotides can confer high specificity of the hybridization signal,
but can result in decreased single-gene specificity or a decreased
sensitivity compared with cDNA arrays. For this reason, most
arrays use different oligonucleotide sequences from the same
gene that are distributed over the slide, ensuring technical
replication of the probed gene sequences use. Microarrays with
different spot geometry and array design are commercially
available. On the widely used Affymetrix oligonucleotide
microarrays, the spotted DNA is present as probe sets consisting
of about 16 probe pairs of 25-mer oligonucleotides. Addition-
ally, the oligonucleotides mostly consist of two sequences, one
set of a perfect match sequence (PM) and the second of a
mismatch sequence (MM) with a single base substitution in theferent procedures for the two most commonly used types of microarrays, spotted
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allows individual subtraction of background hybridization. In
many commercial gene chips, such technical replicates and
measures for assessment of non-specific binding are not
sufficiently realized and must be considered during the
evaluation process of microarray data [6,7].
Typically, the basic technique involves extraction of RNA
from biological samples. The RNA is then copied, while incor-
porating fluorescent nucleotides or tags that are later stained with
fluorescence. The labeled RNA from one sample is then frag-
mented and hybridized to the array. After a certain incubation
time excess RNA is washed off, and the microarray is scanned
under laser light. Grayscale images are generated from the arrays
presenting data that have to be normalized and transformed to
measure relative fluorescence intensities for each element [8].
The starting point for effective data collection and analysis is
a good experimental design with sufficient replicates to ensure
that both the experimental and biological variation will be
minimized. Another important issue in generating expression
data is the optimization and standardization of the experimental
protocol. Like Northern blot and RT-PCR analyses, microarrays
assay relative RNA levels and use these to infer gene expression.
Therefore, at every step in the process, from sample collection
through RNA isolation, array preparation, sample labeling,
hybridization, data collection and analysis, every possible effort
must be made to minimize variation.
3. Bioinformatic analysis of expression data
After the experimental work, the most challenging and rate-
limiting step of microarray analysis is an accurate analysis and
interpretation of the hybridization data. In these analytical steps
thousands of data points need to be converted into reliable and
meaningful biological information. There are now many freely
available and commercial software packages to analyze micro-
array data sets, without one of them answering all questions of
functional genomics. Therefore, the investigator should have a
reasonable understanding of both the analytical techniques and
the biology underlying the experiments. The comparison of
gene expression profiles of two or more experimental states
usually results in long lists of genes with different expression
levels. The challenge is to reduce the complexity to a reasonable
set of genes with significant differences in gene expression.
The first step approaching microarray data is the determi-
nation of basic metric values as absolute levels and fold
changes of gene expression. In DNA microarrays, the ratio of
the two fluorescent dye intensities at any spotted gene sequence
represents the ratio of the corresponding mRNA molecules in
the two samples. Samples that are hybridized against the same
reference sample can be compared to each other. Many
researchers prepare their own reference RNA from a single
cell line or by blending RNA derived from several tissues. For
the profiling of cell lines, the use of pooled RNAs from
different individual cell lines can be an efficient universal
reference sample and allow more reliable comparison of gene
expression between different experiments [9]. Otherwise, the
measurements need to be normalized, which in most casesincludes an adjustment of the overall brightness of each
scanned microarray and the normalization with expression
levels of predefined Fhousekeeping_ genes [8].
Probe-set analysis algorithms applied for oligonucleotide
microarrays create background-adjusted raw intensities and
account for unspecific binding by removing probe sets with
insignificant differences, for instance between single PMs and
MMs. Background adjustment is usually done by dividing the
chip into sectors and ranking the probe cells according to
fluorescence intensities. The extent of probe sets with the lowest
fluorescence intensity is determined by the user. The average
fluorescence intensity of these probe cells is considered as the
‘‘background’’ and subtracted from the mean fluorescence
intensity of all probe cells within the sector. The algorithms make
data from different kinds of microarray only partially comparable,
since gene chips with a pre-selected number of target genes will
result in different background values than genome-wide arrays.
Subsequently, single raw values are calculated for each probe
set from the median of the PM/MM-discrimination values, a step
omitted in arrays not containing mismatch sequences. Some of
the probe-set algorithms assess the significance of the hybrid-
ization result, e.g., by using a one-sided Wilcoxon’s ranked test,
which creates a detection P value that finally allows for the
assignment of detection calls (‘‘absent’’ or ‘‘present’’) to each
transcript. Comparison-algorithms accomplish the normalization
of the data and compute differences between the experiment and
its baseline. The easiest way of normalization before signal value
computation is the adjustment of the overall brightness of each
scanned microarray image by assuming equal RNA quantities
[10]. Other normalization strategies use expression levels of
Fhousekeeping_ genes, splines and normalization algorithms at
the probe intensity level independent or dependent of baseline
arrays [11,12]. Calculation of the differences between PM and
MM as well as between PM and baseline finally results in
logarithmic n-fold values (‘‘log ratio changes’’). Again, a signed
rank test is carried out on the PM and MM differences in a probe
set from the two arrays determining ‘‘change P values’’.
Subsequent analytical techniques usually approach the data
set in an unsupervised fashion with no predefined question or
hypothesis. First of all, genes can be simply ordered according to
their assigned function in order to identify functional systems
involved in the relevant cell responses. Another simple approach
is to rank genes according to their expression levels or similar
expression ratios between different conditions (Fnearest
neighbors_) [13]. Furthermore, different clustering techniques
are used to determine groups of genes with similar patterns of
gene expressions in a data set [14]. Most commonly used is
Fhierarchical clustering_ that builds up a dendrogram of genes
with similar expression patterns [15]. The Fprincipal component
analysis_ represents genes (or samples) in a multidimensional
space along vectors (principal components), thereby revealing
variations between gene groups according to their expression
level. In contrast to this analysis that is restricted to variations
between individual genes, the analysis of Fsupport vector
machines_ creates several mathematical combinations of genes
in order to obtain better separated gene groups in a multidimen-
sional space [8]. It appears from experience that many
Table 1
Advanced analysis tools for microarray data freely available at the web surface
Name Web address Features Reference
FatiGO http://www.fatigo.org and
http://www.babelomics.org
extraction of Gene Ontology (GO) terms significantly
over- or under-represented in a set of gene expression
profiles.
[66,67]
Biosphere http://rook.cecid.hku.hk:8280/
BiosphereServer
interoperates a number of web services like XEMBL,
GetGO, getHAPI and GetUMLS allowing clustering,
visualization of clustering results and retrieval of
sequences, annotations and citations for the genes
of interest.
[68]
ArrayXPath http://www.snubi.org./software/
ArrayXPath/
maps and visualizes microarray data for integrated
biological pathways using Scalable Vector Graphics.
[69]
CARRIE web service http://zlab.bu.edu/CARRIE.web analyzes microarray data and promoter sequence
data to infer transcriptional regulatory networks
from the response to a specific stimulus.
[22]
POBO http://ekhidna.biocenter.helsinki.fi:9801/
pobo
detects, compares and verifies predetermined
transcription factor binding site motifs in the promoters
of one or two clusters of co-regulated genes.
[23]
CONFAC http://morenolab.whitehead.emory.edu/
cgi-bin/confac/login.pl
identifies conserved transcription factor binding sites
in the regulatory region of hundreds of genes at a time.
[24]
GFINDer http://www.medinfopoli.polimi.it/
GFINDer/
provides large-scale lists of user-classified genes with
functional profiles characterizing the different gene
classes biologically and calculates statistical
significances.
[70]
THEA http://thea.unice.fr/ annotates data issued from classification systems with
selected ontology-driven biological information and
allows to either manually search and browse through
these annotations or automatically generate meaningful
generalizations according to statistical criteria.
[71]
GOAL http://microarrays.unife.it GO-based identification of functions and processes
regulated in microarray and SAGE (serial analysis of
gene expression) experiments.
[72]
INCLUSive http://www.esat.kuleuven.ac.be/
inclusive
allows normalization, filtering and clustering of
microarray data, functional scoring of gene clusters,
sequence retrieval, and detection of known and
unknown regulatory elements using probabilistic
sequence models and Gibbs sampling.
[73]
MAPPFinder http://www.GenMAPP.org allows rapid identification of GO terms with
over-represented numbers of gene-expression changes
by integrating the annotations of the Gene Ontology
(GO) Project with the free software package GenMAPP.
[74]
GEPAS http://gepas.bioinfo.cnio.es performs data pre-processing, two-conditions comparison,
unsupervised and supervised clustering and several tests
for differential gene expression among different classes,
continuous variables or survival analysis. A linked tool for
data mining based on Gene Ontology, allows the
convenient analysis of clustering results.
[75,76]
GenePublisher http://www.cbs.dtu.dk/services/
GenePublisher
performs normalization, statistical analysis and
visualization of the data.
Results are run against databases of signal
transduction pathways, metabolic pathways and
promoter sequences in order to extract more information.
[25]
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Name Web address Features Reference
ExpressYourself http://bioinfo.mbb.yale.edu/
expressyourself
performs raw data analysis including background
signal correction, normalization, determination of
score levels of differential hybridization, quality
assessment and combination of replicate experiments.
[77]
ChipInfo http://biosun1.harvard.edu/complab/
chipinfo/
retrieves annotation information from online databases
such as NetAffx and Gene Ontology and organizes such
information into tabular format outputs. Computes related
summary statistics of probe sets and Gene Ontology terms.
[78]
Table 1 (continued)
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constituting the same gene cluster.
FRelevance networks_ [16] or the Fsignificance analysis of
microarrays (SAM)_ [17] are more advanced unsupervised
analytical methods that determine the significance of changes
of gene expression. In creating relevance networks, more than
one data type is used and built up by computing correlation
coefficients between genes or between genes and phenotypic
measurements. Subsequently, the investigator chooses a
threshold by permutation analysis that finally determines the
number of connections between the different features [16].
SAM is the most popular method to calculate false discovery
rates in microarray analysis. The difference of gene expression
of a distinct gene is compared to the distribution of its
expression differences in the permutated set of all sample
categories. This approach unmasks genes that are differentially
expressed at a significant level. In contrast, simple fold-change
methods may result in high false discovery rates, since most
genes are expressed at low levels where random 2-fold changes
are often observed. On the other hand, smaller differences in
gene expression might be rejected by fold-change methods,
even though these differences might be real [17]. Even with the
application of SAM algorithms, it must be considered that
changes in the entire data set composition (e.g., by the use of
fold-change settings within in SAM or FPresent/Absent calls_
for data inclusion) will also affect the permutated data set, and
therefore might substantially alter the final SAM result [18].
More sophisticated analytical tools correlate the results of
microarray analyses with information of other databases, such as
known networks of metabolic or signal transduction pathways or
common promoter elements. The reliability of such meta-
analyses not only depends on the quality of all steps of the
microarray experiment, but also on the quality of the databases
used. Well-kept databases exist for metabolic networks such as
KEGG (Kyoto Encyclopedia of Genes and Genomics) [19] and
EcoCyc (Encyclopedia of Escherichia coli K12 Genes and
Metabolism) [20]. However, due to more variable parameters
that have to be implemented such extensive databases are not yet
available for signaling pathways [21]. To exploit transcriptional
regulatory networks, which are based on consistent regulatory
sequences within promoter elements, different interactive tools
have been meanwhile integrated and are available in the web
surface [22–25] (Table 1). Nevertheless, meta-analysis of
microarray data is often complicated by distinct experimental
platforms and experimental designs.4. Microarray analyses of endothelial stress responses
One of the most intriguing questions for scientists in the field
of inflammatory medicine is as to whether ECs respond to stress
stimuli in more or less stereotype patterns, or whether specific
differences to certain stimuli exist. The microarray technology
allows for the simultaneous detection of expression patterns of
20,000–40,000 gene sequences, and large-scale gene expression
analysis continuously broadens our understanding of the EC
response repertoire involved in inflammation and immune
responses. Among the enormous flood of studies using micro-
array analyses scientists now have to filter for reliable data sets
and convert them into meaningful information. In the following,
we review microarray studies that have been performed to
characterize gene expression profiles in ECs upon induction by
different stress factors. We will point out the potential of such
research and the status of deposition of microarray data in public
databases.We also hope to sensitize the reader to potential pitfalls
that could diminish the quality of microarray experiments.
5. Establishment of endothelial gene expression profiles to
distinct stress stimuli
Tumor necrosis factor (TNF) and bacterial lipopolysaccharide
(LPS) are two of the most potent inflammatory mediators
triggering the induction of a huge number of different genes in
ECs. Consequently, one of the first studies using microarray
technology investigated the effects of LPS in human umbilical
vein endothelial cells (HUVECs) [26]. In order to obtain
reproducible results, the authors analyzed the influence of a
number of experimental parameters including LPS and serum
concentrations, and studied the cells in duplicate kinetic data sets.
This study demonstrated not only the feasibility of microarray
analysis of endothelial cells, but also identified 38 inducible
genes with an up to 11-fold upregulation. In addition to several
known genes such as established NF-nB target genes, a number
of unknown genes that had been previously not implicated in the
LPS response of endothelial cells were found. The relatively
small number of LPS-induced genes identified in this study was
presumably due to the number of only 4000 genes that had been
spotted on nylon membranes, at a time when microarray analysis
was still in its infancy. Nonetheless, a kind of a hype-and-hope
phase started that was fueled by the excitement about the
feasibility of microarray technology in endothelial cells and the
possibility to identify novel pro-inflammatory genes.
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of TNF-stimulated ECs [6,27–31]. Surprisingly, however, even
though similar cells and stimuli were used in these studies, the
reported results were often considerably diverse and only
partially overlapping. This variability underscores the necessity
of statistical evaluation and certain quality and standardization
criteria in microarray measurements. A sufficient number of
independent experiments and technical replicates, exclusion of
unspecific binding, and a careful statistical analysis all
represent essential quality factors ensuring a high confirmation
rate of the data in independent experiments.
Several groups also compared the effects of different
inflammatory mediators with the TNF-induced gene profile.
Generally, a broad consistency with TNF-induced gene profiles
was found for LPS-, C5a- and IL-1h-regulated gene expression
[7]. These studies mainly used hierarchical clustering for
analysis, but attempts to identify regulatory pathways of
transcription were not yet pursued or remained rudimentary.
Furthermore, no bioinformatic tools were applied to investigate
potential differences in the genetic responses to individual pro-
inflammatory stimuli.
6. Elucidation of shear stress-induced endothelial gene
response patterns
Another area extensively approached by microarray analysis
is the endothelial response to shear stress, which has been
implied as an important pathogenic trigger of atherosclerosis. An
early study revealed 52 up- and down-regulated genes following
shear stress, including several genes encoding pro-inflammatory
cytokines [32]. Interestingly, many of the genes identified as
shear stress-responsive had been previously implicated in the
production of NO, which is triggered by shear stress and
involved in regulation of the vascular tone. A consecutive and
statistically more profound study analyzed kinetic expression
profiles in shear-stressed HUVECs [33]. Thereby, the list of up-
and down-regulated genes was reduced to a number of 39
reliable genes, confirming former hypotheses of an up-regula-
tion of genes involved in antioxidant defense and a down-
regulation of genes involved in DNA synthesis and cell cycle
control. Furthermore, a recent report aimed at identifying genes
which showed a sustained and unique expression during shear
stress, but were not induced by pro-inflammatory cytokines [34].
Transcriptional profiling identified 12 of 18,000 genes that were
modulated at least 5-fold after 24 h of steady laminar flow. After
a 7-day exposure only 3 of 12 genes remained elevated at this
level. Most flow-induced genes were also induced by TNF,
however, certain genes including the transcriptional regulator
lung Kruppel-like factor (LKLF/KLF2) and cytochrome P450
1B1 were uniquely expressed by flow stress.
7. Microarray analysis approaching endothelial gene
responses to less common stress stimuli
In a few studies, the analysis of global gene profiles has been
used to address specific aspects of endothelial pathophysiology.
For instance, heme oxygenase-1 (HO-1) plays an important rolein the protection of ECs from oxidative stress. Since HO-1
expression progressively declines in quiescent human micro-
vessel ECs, Abraham et al. attempted to identify genes
differentially regulated in ECs overexpressing HO-1 [35]. In
three independent experiments, microarray and subsequent RT-
PCR analyses could identify 30HO-1-regulated genes. Several of
the upregulated genes encoded for growth factors such as VEGF
or were involved in cell cycle progression, such as cyclin E and
D. In contrast, downregulated genes comprised several apoptosis
regulators and the cyclin-dependent kinase inhibitors p21 and
p27. The study therefore demonstrated that HO-1 participates not
only in the regulation of cell cycle progression, but can also
launch a defense program against multiple forms of stress.
To shed light on regulatory pathways induced by nicotine,
Zhang et al. [36] determined gene alterations in human coronary
artery cells by microarray analysis. Cigarette smoking causes
vascular endothelial dysfunction and is a major risk factor for
cardiovascular diseases. Nicotine, a major constituent of
cigarette smoke, has been shown to alter gene expression in
ECs, however, the underlying regulatory pathways are largely
unknown. The authors identified phosphatidylinositol phos-
phate kinase, diacyglycerol kinase, cAMP response element-
binding protein (CREB) and NF-nB as the principal nicotine-
induced transcription factors and signal mediators. These data
might be therefore relevant to understand the mechanisms
underlying the pathophysiological effect of nicotine, particularly
on endothelial function and the pathogenesis of atherosclerosis.
8. Microarray analysis as a screening tool for endothelial
stress responses
Without the claim of completeness in gene profiling, micro-
array analysis is often used as a first screening tool. In this context,
microarray analyses might give a rough glimpse of gene
expression, which can provide new ideas and hypotheses of
endothelial gene responses. Certain aspects of the endothelial
response can then be investigated in more detail by additional
techniques and functional studies. Such an approach was realized
by our group analyzing the functional effects of myeloid-related
proteins (MRP)-8 and -14 in human microvascular endothelial
cells [37]. Both proteins that generally form a complex are
released by activated phagocytes. Upon incubation of HUVECs
with purified MRP8/MRP14, we found 22 endothelial genes that
were significantly altered in their transcription. Data analysis
revealed that these genes could be assigned to three functional
categories, i.e., genes involved in platelet aggregation, inflam-
mation, and endothelial permeability. Indeed, all effects ofMRP8/
MRP14 could be verified in subsequent functional studies. For
example, the hypothesis that MRP8/MRP14 negatively affected
endothelial integrity was confirmed by demonstrating an MRP8/
MRP14-induced loss of transendothelial resistance and a con-
comitant increase of endothelial permeability, effects that are
typically found at local sites of inflammatory reactions.
Another study recently employed cDNA microarrays as a
screening approach for the identification of novel thrombin-
responsive genes in HUVECs [38]. Thrombin mediates most of
its cellular responses through activation of transmembrane G
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tors (PARs). Thrombin-induced signaling in EC results in a
number of phenotypic changes, many of which are presumably
mediated through the induction of newly synthesized proteins.
Microarray analysis identified seven responsive genes consis-
tently upregulated by thrombin in two independent experiments,
although only a 2-fold induction was observed. Among them,
CL-100, a dual-specificity phosphatase, also known as MAP
kinase phosphatase-1 (MKP-1), showed the greatest induction
by thrombin [38]. Further functional analysis suggested that CL-
100 phosphatase and its subsequent regulation of ERK activity
play a key regulatory role in the thrombin signaling pathway and
transcriptional regulation of endothelial cell activation genes.
Microarray analyses with high n-fold regulations might
even be performed without replicates, as long as they remain
screening tools, and the criteria for relevant gene regulation are
strictly chosen. In this respect, an interesting study was recently
performed to examine the molecular mechanisms in hemolytic
uremic syndrome induced by enterohemorrhagic Escherichia
coli (EHEC) [39]. EHEC produces Shiga toxins which are
assumed to cause cell damage through the modulation of
protein synthesis. Microarray and subsequent RT-PCR analyses
revealed that incubation of ECs with sublethal concentrations
of Shiga toxin elicited few, but reproducible changes in the
expression of genes, which mostly encoded chemo- and
cytokines. Although the array data reported in this study are
of limited value to define a complete gene profile, they might
unravel novel aspects of bacteria/host interactions.
Microarray analysis was also used to study the effect of
cytotoxic necrotizing factor (CNF)-1, another virulence factor
of E. coli [40]. CNF1 acts at the molecular level by modulating
the activity of Rho GTPases. It was found that incubation of
HUVECs with CNF-1 triggered a rapid pro-inflammatory
response that included gene induction of monocyte chemotac-
tic protein-1 (MCP-1), interleukin-8 (IL-8), IL-6, monocyte
inflammatory protein-3a (MIP-3a) and E-selectin. Although
the data were based on a single microarray analysis,
subsequent experiments found that induction of MIP3a,
MCP-1 and IL-8 was indeed Rho-dependent.
A technically sophisticated study was performed to elucidate
the genetic program elicited by the endothelial PAS domain
protein 1 (EPAS1) [41]. EPAS1 is a member of the basic helix–
loop–helix/PAS domain-containing transcription factor family
and has a high homology to HIF-1. Upon adenoviral expression
of EPAS1 in HUVECs, microarray analysis could identify a total
of 130 upregulated genes. The statistical significance of these
findings was not reported, however, more than half of the genes
were confirmed to be upregulated by Northern blot analysis or
RT-PCR. These included VEGF, Flt-1, Flk-1, and Tie2.
Furthermore, the authors found that EPAS1 gene delivery also
promoted the angiogenic process in vivo.
9. Identification of endothelial signaling pathways by
combining microarray analysis with other molecular tools
Assignment of specific gene expression patterns to distinct
signaling pathways might be also accomplished by a combina-tion of microarray analysis with additional molecular techniques.
For instance, microarray analyses have been employed following
the selective blockade of certain signaling modules. In the TNF
pathway an important adapter protein is the TNF-receptor 1-
associated death domain protein (TRADD). Microarray analysis
was performed in TNF-stimulated HUVEC following TRADD
depletion by antisense oligonucleotides [42]. The authors
revealed that expression of 20 out of 24 genes, which showed
a 5-fold or greater increase in TNF-induced mRNA expression,
was significantly inhibited by TRADD depletion. Most of the
gene expression attenuated by TRADDdepletion involved target
genes of the transcription factorsNF-nB andAP-1,which are key
components of TNF-induced gene expression.
Microarray analysis has been recently also performed to
investigate the role of STAT4, which is normally phosphorylated
and activated by IL-12 and IFN-a. In HUVECs, however,
STAT4 was shown to be activated by IFN-a, but not by IL-12
due to the lack of both subunits of the IL-12 receptor [43]. In
order to selectively identify STAT4-induced genes in ECs, the
authors analyzed IL-12 responses in IL-12 receptor-transduced
ECs and IFN-a responses in STAT4-overexpressing EC and
neuroblastoma cells. DNA microarray and subsequent quanti-
tative RT-PCR, together with a restricted selection of genes,
resulted in only two inducible genes of about 16,000 spotted
genes, which were monocyte chemoattractant protein 1 (MIP-1)
and suppressor of cytokine signaling 3 (SOCS-3) [43]. These
results revealed the first time that ECs trigger a STAT4-mediated
response that might modulate their inflammatory behavior.
A crucial mediator of vascular development and homeostasis
is also transforming growth factor (TGF)-h, which modulates
transcription of various target genes through different surface
receptors. Activin receptor-like kinase 5 (ALK-5) and ALK-1
are both TGF-h type I receptors, which have a distinct cell type
specificity and engage different signaling pathways. To
investigate the role of ALK-1 and ALK-1, Ota et al.
adenovirally transduced HUVECs with constitutively active
forms of the two receptor-like kinases [44]. Gene profiling
revealed remarkable differences in the transcriptional targets of
ALK-1 and ALK-5. From approximately 7,000 genes 46 genes
were upregulated by ALK-1 and 52 genes upregulated by ALK-
5. Both receptors also downregulated distinct target genes. It is
noteworthy, however, that although the array experiment was
partially confirmed by Northern blot and RT-PCR analyses, a
low (2-fold) threshold of regulation was chosen in this study,
and no replicates were performed. Therefore, the established
gene expression profiles triggered by ALK-1 and ALK-5
certainly require further validation.
Inflammatory activation of ECs is controlled by multiple
signaling pathways. While NF-nB has an established role as an
important signaling module, the contribution of other pathways
for induction of distinct gene expression patterns in ECs is
widely unknown. Using targeted interruption of the NF-nB
pathway by transfection of a dominant-negative InB kinase, we
have recently found that TNF signaling is almost completely
dependent on a functional NF-nB response, whereas other
pathways such as MAP kinases only play a minor role [30].
These and other investigations, which are based on multiple
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expression patterns to specific endothelial signaling pathways.
10. Advanced bioinformatic analysis of endothelial
signaling networks
Data acquisition of gene responses on a genome-wide scale
represents an enormous chance to apply advanced bioinfor-
matic tools in order to identify distinct patterns turned on in
signaling networks. A sophisticated application of bioinfor-
matics and databases was realized by Mayer et al. [45]. The
authors established a kinetic profile of IL-1-regulated genes in
HUVECs over five independent time points, although only a
single chip analysis was performed for each time point. A total
of 137 genes were found to be regulated >4-fold, including 18
transcription factors. Cluster analysis was performed in order to
group the identified genes according to their expression
profiles. To identify novel transcription factor-binding sites,
the corresponding promoters were then extracted from data-
bases and analyzed for regulatory elements that were over-
represented in specific clusters. Thereby, the authors could
identify several novel DNA-binding sites involved in IL-1-
induced activation of ECs. This approach also demonstrated
the feasibility of using public databases and bioinformatics to
discover novel regulatory mechanisms.
As mentioned above, there is now sophisticated freeware
available that allows for the evaluation of gene expression
results in public databases of signal transduction pathways,
metabolic pathways or promoter sequences in order to extract
maximal information of microarray data [22–25] (Table 1).
Such tools have not yet been employed to study inflammatory
gene responses in ECs, but promise interesting results when
applied to reliable gene expression profiles.
11. Pitfalls in microarray analyses of ECs
It is fair to state that the initial excitements of microarray
application are now accompanied by a more sound recognition
of its various traps and pitfalls. Even if the very same RNA
sample is analyzed on a series of repetitive chips, one often has
to deal with considerable signal variability for the same gene.
Studies addressing the reproducibility of microarray data
suggested several substantial problems regarding the signal-
to-noise ratio [46–52]. Also, careful attention must be paid as
to which system is selected for microarray experiments. There
are considerable quality differences in microarrays and analysis
platforms depending on the manufacturer [52]. Vendors of
high-quality gene chips usually put enormous efforts into
production processes, such as the design, synthesis and
printing of the oligonucleotides or cDNAs, in order to reduce
chip-to-chip variations and to improve the reliability of
hybridization experiments. Other sources of variability that
have to be taken into account include differences in sample
preparation, probe labeling, washing protocols, hybridization
artifacts, signal scanning as well as subtle gene-to-gene
differences in hybridization efficiency. Laboratory measures
such as the assurance of a sufficient amount of RNA,standardized sample preparation and labeling (quick RNA
extraction and purification, linear amplification, equal labeling
with fluorochromes etc.) are essential steps of quality control
steps that minimize the signal-to-noise ratio of the scanning
result. A sophisticated analysis platform includes data collecting
software, which is able to detect hybridization artifacts and
allows the visual control of the hybridization results. Hybrid-
ization controls visualize abnormalities in the hybridization
pattern, allow the computation of the overall signal intensity,
screen for the intactness of the input RNA and detect the
background noise ratio, e.g., represented by the percentage of
Fpresent calls_. Appropriate mathematical algorithms then use
scaling factors and normalize primary data with inhomogeneous
hybridization. Certain Fprobe set algorithms_ not only rely on
intra-chip normalization and scaling, but also detect statistical
outliers (chips, probe sets or individual probe pairs). The
appropriate data analysis software has too be chosen according
to the intrinsic noise level of the relevant project [46,51].
Nevertheless, the biggest obstacles researchers face is not
the manufacture and use of microarrays at the bench, but the
biological variability. To meet this challenge production of
replicate data and proper experimental design remain the most
important steps to improve the reliability of expression
measurements. In the context of endothelial cell biology, we
have repeatedly observed that parameters such as the EC type,
the culture medium or degree of cell confluency in the tissue
flask substantially influence the gene expression profiles, even
after stimulation with potent stress stimuli such as TNF. In
primary ECs, the reliability of gene expression data strongly
depends on the cell homogeneity and the passage number, as
shown for instance for high endothelial venule ECs [53].
Additionally, genes with low expression levels do not follow a
normal distribution, which actually excludes the application of
parametric statistical tests [49]. Due to this fact, reproducibility
may be poor across different samples and fold-changes may
appear inadequately high [49,54,55]. Therefore, conclusions
drawn from array results based on low numbers of biological
replicates have to be evaluated with caution. Gene expression
profiling lacking statistical validation will inevitably lead to
false data and will be of no use for independent investigators.
In order to account for the many biological variables which
still exclude the use of microarray analysis as a stand-alone
technique, further validation is needed [56,57]. Direct confir-
mation of the gene expression profile can be accomplished by
semi-quantitative or real-time RT-PCR, Northern blot analysis
or in situ hybridization. However, these assays are not feasible
for genome-wide analysis and are rather confined to a selection
of genes. They can be performed with the same samples used
for array hybridization or with new samples verifying the
universality of the results. The most appealing question is
certainly whether changes in gene expression are also reflected
by alterations at the protein level. To follow changes in protein
expression, standard techniques such as Western blot analysis,
flow cytometry or immunohistochemistry can be performed for
selected gene products [56]. A more global approach is realized
by proteome technologies and different approaches using mass
spectrometry [58,59].
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homogenous cell populations can be synchronized in cell
progression, and therefore allow sampling at distinct and
comparable time points. All these attributes are important
factors lowering the biological variability of experiments with
ECs. Certainly, results with immortal cell lines also argue for
caution and may not reflect the true in vivo situation. In
addition, endothelial cell lines have different origin and can be
derived from the micro- or macrovascular beds or from
differentiated tissue-specific endothelial cells. Thus, a note of
caution is certainly advisable when interpreting genetic
responses of endothelial cell lines.
12. Gene expression databases
The establishment of databases containing freely accessible
and peer-reviewed microarray data sets is of enormous value
for the scientific community and will help to save redundant
efforts and financial resources. Furthermore, analyses compar-
ing data sets produced by different laboratories can increase the
confidence in expression results. In fact, many researchers in
the microarray community are starting to push the field toward
a point where scientists will be able to accurately compare
results from different laboratories, which so far has been rather
problematic. Several large gene expression databases are
already accessible with different user friendliness and possi-
bilities of database integration (Table 2).
Some progress has been made, in particular under the
auspices of the Mircroarray Gene Expression Data (MGED)
Society, in establishing common standards. This includes
checklists for describing microarray data, systems for data
management and public repositories for data storage and
mining. An essential prerequisite for the admittance of
microarray data into public databases is to be MIAME
(minimum information about a microarray experiment)-
compatible [60,61]. This requirement aims at providing
information about the experimental design, preparation and
labeling of the samples, hybridization conditions, and speci-
fications and normalization controls. Only this minimal
standardization of information about all stages of a microarray
experiment will allow for almagation of array data of different
laboratories and sources in a public domain, permitting
advanced bioinformatic usage and data mining. Indeed,
complying with MIAME has now also become essential for
publishing array data in several journals.Table 2
Public databases comprising microarray data of human gene profiles
Name Institution
ArrayExpress European Bioinformatics Institute
Center for Information Biology gene
Expression database (CIBEX)
Microarray Gene Expression Dat
DDBJ (DNA Data Bank of Japan) National Institute of Genetics (NI
Gene Expression Omnibus (GEO) National Center for Biotechnolog
Cancer Genome Anatomy Project National Cancer Institute
Stanford Microarray Database School of Medicine, Stanford Un
Human Gene Expression Index Harvard Institutes of MedicineHowever, many of the commonly microarray platforms and
databases have different analysis tools. Therefore, even if data-
reporting guidelines such as MIAME are fulfilled, database
meta-analysis will remain complicated due to differences in
experimental technologies, data processing, database formats,
and inconsistent gene and sample annotation, which makes it
difficult to generate cross-platform guidelines for data inter-
pretation [14,46]. In fact, a low intra- and inter-database
consistency between different databases importing expression
profiles has been recently noted, and a satisfying correlation
was only found between replicate experiments of oligonucle-
otide microarray data [62].
Standardization of microarray data, analysis and interpreta-
tion holds the potential for large-scale analysis and could
enable its access for clinical trials in inflammatory medicine.
The main goal will be to integrate different databases contain-
ing expression data, promoter information, signal transduction
networks and other information [61,63]. One of the key factors
that will decide about the future success of applying micro-
arrays to biological and clinical issues therefore is standardi-
zation, both in an experimental and computational sense.
13. Outlooks for microarray analyses in ECs
A post-genomic challenge is to move from genomic DNA
sequences to a complete understanding of gene function and
biological processes. Microarray technologies offer certainly
one of the key components in enabling an eventual FSystems
Biology_ approach. To this end, inclusion of multiple platforms
and corroboration of data from a variety of formats will be
required. The future relevance of microarrays analyses will be
further increased by implementation of additional modern
techniques of molecular biology and genetics. For instance,
chromatin immunoprecipitation (CHIP) is a powerful technique
to determine the activity of transcription factors under defined
conditions in vivo, and integration of this method could
provide detailed insights into cellular signaling networks
[64,65]. To this end, DNA from stimulated cells is immuno-
precipitated with antibodies detecting specific DNA-binding
proteins. The isolated DNA fragments are the amplified by
non-specific PCR and processed for hybridization on micro-
arrays presenting known promoter sequences (CHIP on Chip).
Thereby, this approach allows the determination of active
binding sites in promoter regions of genes in vivo on a
genome-wide scale. The combination of such data with mRNAWeb address
(EBI) http://www.ebi.ac.uk/arrayexpress
a (MGED) Society http://cibex.nig.ac.jp/index.jsp
G), Mishima, Japan http://www.ddbj.nig.ac.jp/
y Information (NCBI) http://www.ncbi.nih.gov/geo
http://www.cgap.nci.nih.gov
iversity http://genome-www5.stanford.edu/
http://zlab.bu.edu/HugeIndex/databases.htm
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with promoter microarrays will be very helpful for the large-
scale analysis of binding site profiles and the global exploration
of signaling networks.
In endothelial biology, a major challenge is the heterogene-
ity of different endothelial subtypes in various tissues. The
progress expected in linear RNA amplification techniques will
allow analysis of expression patterns of defined endothelial
phenotypes in situ, for instance by analysing RNA expression
directly from microdissected tissue biopsies. Such approaches
will enable to define endothelial response mechanisms under
defined inflammatory conditions and might allow the identi-
fication of novel targets for anti-inflammatory strategies.
However, still great efforts are still required in bioinformatics,
standardization and data mining, before microarray technology
can be transformed from a research tool to clinical applications.
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